Stereotaxis STXS
NYSE STXS
$1.30 -0.02 (-1.52%)
As of: Sep 10, 2026 · 3:59 PM EDT

Stereotaxis (STXS) Non-Current Assets (2010 - 2026)

Stereotaxis' (STXS) quarterly Non-Current Assets came in at $18.0 million in Q1 2026, down 9.04% year-over-year from $19.8 million in Q1 2025, and down 2.17% quarter-over-quarter from $18.4 million in Q4 2025.

Analysis

Stereotaxis (STXS) Non-Current Assets (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Non-Current Assets for 17 consecutive years, with $18.0 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 9.04% year-over-year to $18.0 million in Q1 2026; TTM through Mar 2026 was $74.6 million, a 6.35% increase from a year earlier, with the FY2025 full-year figure at $18.4 million, down 9.28% from the prior year.
  • Non-Current Assets was $18.0 million for Q1 2026 at Stereotaxis, down from $18.4 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $22.1 million in Q3 2024 and troughed at $7.9 million in Q2 2024.
  • A 5-year average of $13.6 million and a median of $10.2 million in 2022 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets soared 377.76% in 2022 and fell 15.93% in 2024, its largest moves.
  • Over 5 years, Non-Current Assets stood at $10.2 million in 2022, then retreated by 15.0% to $8.6 million in 2023, then soared by 134.73% to $20.3 million in 2024, then declined by 9.28% to $18.4 million in 2025, then dropped by 2.17% to $18.0 million in 2026.
  • The last three Non-Current Assets figures came in at $18.0 million (Q1 2026), $18.4 million (Q4 2025), and $18.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 68.92 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 7.05 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 2.37 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 8.29 Bn
10 Stereotaxis 129.55 Mn 114.93 Mn 3.79 Mn 18.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 18.00 Mn
Dec 31, 2025 18.40 Mn
Sep 30, 2025 18.92 Mn
Jun 30, 2025 19.27 Mn
Mar 31, 2025 19.79 Mn
Dec 31, 2024 20.29 Mn
Sep 30, 2024 22.12 Mn
Jun 30, 2024 7.94 Mn
Mar 31, 2024 8.24 Mn
Dec 31, 2023 8.64 Mn
Sep 30, 2023 9.01 Mn
Jun 30, 2023 9.41 Mn
Mar 31, 2023 9.81 Mn
Dec 31, 2022 10.17 Mn
Sep 30, 2022 10.00 Mn
Jun 30, 2022 10.04 Mn
Mar 31, 2022 10.30 Mn
Dec 31, 2021 9.60 Mn
Sep 30, 2021 8.51 Mn
Jun 30, 2021 2.10 Mn